BIOCRYST PHARMACEUTICALS INC — Director's Dealing 2017

Sep 5, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOCRYST PHARMACEUTICALS INC (BCRX)
CIK: 0000882796
Period of Report: 2017-09-01

Reporting Person: Hutson Nancy J (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-09-01	Common Stock	A	1960	$5.10	Acquired	34167	Direct

Footnotes

F1: Shares of Common Stock issued to the reporting person in lieu of quarterly cash Board Member retainer of $10,000.